erythromycin has been researched along with afn 1252 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Johnson, ME; Kwon, J; Mehboob, S; Mistry, T; Ren, J | 1 |
1 other study(ies) available for erythromycin and afn 1252
Article | Year |
---|---|
A novel series of enoyl reductase inhibitors targeting the ESKAPE pathogens, Staphylococcus aureus and Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Cell Survival; Dose-Response Relationship, Drug; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Escherichia coli; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship | 2018 |